نتایج جستجو برای: anthracyclines

تعداد نتایج: 3200  

Journal: :Cancer research 1988
A S Tsiftsoglou W Wong S H Robinson

Experiments were performed with K562 erythroleukemia cells to further characterize the observation that hemin protects hemopoietic cells from the cytotoxic effects of anthracycline drugs. The present studies demonstrate that this protective effect of hemin applies only to anthracyclines and not to other classes of antineoplastic agents. Hemin interferes with the cellular accumulation of various...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2012
S Ladoire G Mignot C Dalban A Chevriaux L Arnould C Rébé L Apetoh R Boidot F Penault-Llorca P Fumoleau H Roché M Spielmann C Levy A Lortholary F Eichler C Mesleard F Bonnetain F Ghiringhelli

BACKGROUND Predictive markers of response to chemotherapy are lacking in breast cancer patients. Forkhead Box Protein 3 (FOXP3) is an anti-oncogene whose absence in cancer cells could confer resistance to DNA damaging agent. So we made the hypothesis that FOXP3 expression predicts the response to anthracyclines in breast cancer patients and that adjuvant chemotherapy adding taxanes to anthracyc...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2011
M Aapro C Bernard-Marty E G C Brain G Batist F Erdkamp K Krzemieniecki R Leonard A Lluch S Monfardini M Ryberg P Soubeyran U Wedding

BACKGROUND Comorbidities and risk factors likely to complicate treatment are common in elderly cancer patients. Anthracyclines remain the cornerstone of first-line therapy for non-Hodgkin's lymphoma (NHL) and metastatic and early breast cancer but can cause congestive heart failure. Elderly patients are at increased risk of this event and measures to reduce it should be considered. METHODS A ...

Introduction: Anthracyclines are one of the classes of chemotherapy drugs that  are widely used to treat many types of cancers including breast cancer. Taking this class of medications has a significant relationship with cardiac dysfunction. N-acetylcysteine has antioxidant properties and may be effective in preventing cardiac dysfunctions. In this study, we investigated the effect of N-acetylc...

2015
Derek W. Edwardson Rashmi Narendrula Simon Chewchuk Kyle Mispel-Beyer Jonathan P.J. Mapletoft Amadeo M. Parissenti

Many clinical studies involving anti-tumor agents neglect to consider how these agents are metabolized within the host and whether the creation of specific metabolites alters drug therapeutic properties or toxic side effects. However, this is not the case for the anthracycline class of chemotherapy drugs. This review describes the various enzymes involved in the one electron (semi-quinone) or t...

2012
David Montaigne Christopher Hurt Remi Neviere

Anthracyclines remain the cornerstone of treatment in many malignancies but these agents have a cumulative dose relationship with cardiotoxicity. Development of cardiomyopathy and congestive heart failure induced by anthracyclines are typically dose-dependent, irreversible, and cumulative. Although past studies of cardiotoxicity have focused on anthracyclines, more recently interest has turned ...

Journal: :Biochemical pharmacology 1995
H S Mülder H Dekker H M Pinedo J Lankelma

We have used a new methodology to measure the activity of P-glycoprotein (P-gp) in multidrug-resistant (MDR) tumor cells. This activity leads to a lower cytosolic concentration and a lower cytotoxicity of the classical anthracyclines, daunorubicin (DNR), and doxorubicin (DOX). It has been reported that the anthracycline idarubicin (IDA), which is more lipophilic, has a higher clinical efficacy ...

Journal: :Archives of Disease in Childhood 1994

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید